Pigmentation
Changes in Skin Color: Clinical Perspectives
Skin Cancer
Cancer Therapies
Cancer Therapies
Treatment Resistant Cancers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 20, 2026

Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
Israe El Ghazouli1, Salim Gallouj1, Ouiame El Jouari1
1Dermatology Department, Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, University Hospital Mohammed VI, Tangier, MAR.
Cyclin-dependent kinase (CDK) 4/6 inhibitors like ribociclib can cause rare vitiligo-like skin depigmentation in breast cancer patients. Early recognition and management are crucial for continued treatment and quality of life.
Area of Science:
Background: